Emage Fibroid Centers thanks Detroit and Southfield mayors for Fibroid Awareness Month proclamations

Emage Fibroid Centers thanked Detroit Mayor Mary Sheffield and Southfield Mayor Ken Siver on July 21 for proclaiming July 2026 as Fibroid Awareness Month. The recognition comes as the center pushes its Freedom from Fibroids campaign to raise awareness of uterine fibroids and nonsurgical treatment options like uterine fibroid embolization.

Why it matters: - The proclamations put a local spotlight on uterine fibroids, a condition that can disrupt health, fertility and quality of life for millions of women. - The recognition also helps elevate awareness of nonsurgical treatment options, which can expand choices for patients who may otherwise be steered toward surgery. - The issue has a disproportionate impact on Black women, making awareness and access to care a health equity issue as well as a medical one.

What happened: - Emage Fibroid Centers thanked Detroit Mayor Mary Sheffield and Southfield Mayor Ken Siver for proclaiming July 2026 as Fibroid Awareness Month. - John Lipman, founder and chief medical officer of Emage Fibroid Centers, said the proclamation helps promote greater awareness of uterine fibroids and the need for accurate information, timely diagnosis and appropriate treatment options. - Lipman described fibroids as a “silent epidemic” that disproportionately affects women of color. - Mayor Sheffield and Mayor Siver issued proclamations recognizing the impact fibroids have on women and the fact that the condition remains underdiagnosed and often misunderstood. - The mayors also recognized organizations like Emage for educating communities, amplifying patient voices and encouraging conversations about women’s health.

The details: - Uterine fibroids are benign growths that develop in or on the uterus. - Fibroids affect up to 80% of women by age 50. - Common symptoms include abnormal uterine bleeding, severe pelvic pain, anemia, fatigue, fertility challenges and pregnancy complications. - Black women experience higher rates of fibroids, earlier onset, more severe symptoms and higher rates of invasive surgery. - The National Institutes of Health has said Black women are seven times as likely to have surgery and twice as likely to undergo a hysterectomy for fibroids as white women, even though minimally invasive, nonsurgical options exist. - Philip Adler, medical director of Emage Fibroid Centers-Detroit, said many women do not know they may be candidates for uterine fibroid embolization, or UFE. - UFE is a nonsurgical procedure that shrinks fibroids and reduces symptoms so women can return to daily life. - UFE is performed through a single small nick in the skin and works by blocking blood flow to fibroids, causing them to soften and shrink. - The procedure preserves the uterus while easing heavy bleeding and pelvic pain. - The American College of Obstetricians & Gynecologists endorsed UFE in 2008, but the procedure remains relatively unknown. - Emage Fibroid Centers says its Detroit-area location is in Southfield and is one of the only outpatient centers in Metro Detroit specializing in UFE. - Emage launched its Freedom from Fibroids campaign during Fibroid Awareness Month to encourage women with symptoms to talk with their doctor and review all treatment options, including UFE. - More information is available in the company's announcement.

Between the lines: - The proclamations signal that fibroid care is moving further into public-health and community-awareness territory, not just a specialist medical issue. - The emphasis on UFE suggests Emage is trying to close an information gap around a procedure that exists, has professional endorsement and may reduce the need for more invasive surgery. - The repeated focus on women of color points to broader disparities in diagnosis and treatment that awareness campaigns alone may not solve.

What's next: - Emage will continue promoting its Freedom from Fibroids campaign throughout Fibroid Awareness Month. - The company is encouraging women with symptoms to seek medical advice and learn about nonsurgical options before moving to more invasive care. - Public awareness efforts are likely to continue as fibroids remain common, underdiagnosed and unevenly treated.